189 related articles for article (PubMed ID: 17033171)
1. Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminata.
Yan J; Chen SL; Wang HN; Wu TX
Dermatology; 2006; 213(3):218-23. PubMed ID: 17033171
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
Komericki P; Akkilic-Materna M; Strimitzer T; Aberer W
Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod for anogenital warts in non-immunocompromised adults.
Grillo-Ardila CF; Angel-Müller E; Salazar-Díaz LC; Gaitán HG; Ruiz-Parra AI; Lethaby A
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010389. PubMed ID: 25362229
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
[TBL] [Abstract][Full Text] [Related]
5. New treatments for genital warts less than ideal: abstract and commentary.
Fife KH
JAMA; 1998 Jun; 279(24):2003-4. PubMed ID: 9643868
[No Abstract] [Full Text] [Related]
6. [A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France].
Lafuma A; Monsonego J; Moyal-Barracco M; Pribil C
Ann Dermatol Venereol; 2003; 130(8-9 Pt 1):731-6. PubMed ID: 14576602
[TBL] [Abstract][Full Text] [Related]
7. Treatment of genital warts with an immune-response modifier (imiquimod).
Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
[TBL] [Abstract][Full Text] [Related]
8. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
9. New approach to managing genital warts.
Lopaschuk CC
Can Fam Physician; 2013 Jul; 59(7):731-6. PubMed ID: 23851535
[TBL] [Abstract][Full Text] [Related]
10. The diagnosis and treatment of human papillomavirus-mediated genital lesions.
Brodell LA; Mercurio MG; Brodell RT
Cutis; 2007 Apr; 79(4 Suppl):5-10. PubMed ID: 17508490
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic approaches to genital warts.
Beutner KR; Ferenczy A
Am J Med; 1997 May; 102(5A):28-37. PubMed ID: 9217660
[TBL] [Abstract][Full Text] [Related]
12. A short, 8-week course of imiquimod 5% cream versus podophyllotoxin in the treatment of anogenital warts: A retrospective comparative cohort study.
Nicolaidou E; Kanelleas A; Nikolakopoulos S; Bezrodnii G; Nearchou E; Gerodimou M; Papadopoulou-Skordou E; Paparizos V; Rigopoulos D
Indian J Dermatol Venereol Leprol; 2021; 87(5):666-670. PubMed ID: 31650979
[TBL] [Abstract][Full Text] [Related]
13. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of condylomata acuminata in women. A placebo-controlled, double-blind study.
Syed TA; Lundin S; Ahmad SA
Dermatology; 1994; 189(2):142-5. PubMed ID: 8075441
[TBL] [Abstract][Full Text] [Related]
14. Modern management of external genital warts.
Mayeaux EJ; Dunton C
J Low Genit Tract Dis; 2008 Jul; 12(3):185-92. PubMed ID: 18596459
[TBL] [Abstract][Full Text] [Related]
15. Topically applied treatments for external genital warts in nonimmunocompromised patients: a systematic review and network meta-analysis.
Jung JM; Jung CJ; Lee WJ; Won CH; Lee MW; Choi JH; Chang SE
Br J Dermatol; 2020 Jul; 183(1):24-36. PubMed ID: 31675442
[TBL] [Abstract][Full Text] [Related]
16. Treatment of anogenital warts in children with topical 0.05% podofilox gel and 5% imiquimod cream.
Moresi JM; Herbert CR; Cohen BA
Pediatr Dermatol; 2001; 18(5):448-50; discussion 452. PubMed ID: 11737696
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
Beutner KR; Tyring SK; Trofatter KF; Douglas JM; Spruance S; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Antimicrob Agents Chemother; 1998 Apr; 42(4):789-94. PubMed ID: 9559784
[TBL] [Abstract][Full Text] [Related]
18. Treatments for genital warts.
Cook K; Brownell I
J Drugs Dermatol; 2008 Aug; 7(8):801-7. PubMed ID: 18720702
[No Abstract] [Full Text] [Related]
19. Long-term follow-up of endoscopic therapy of anal canal condylomata acuminata with podophyllotoxin.
Tzathas C; Stavrianeas NG; Triantafyllou K; Triantafyllou G; Ladas SD
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):364-7. PubMed ID: 17309460
[TBL] [Abstract][Full Text] [Related]
20. Human leukocyte interferon-alpha versus podophyllotoxin in cream for the treatment of genital warts in males. A placebo-controlled, double-blind, comparative study.
Syed TA; Cheema KM; Khayyami M; Ahmad SA; Ahmad SH; Ahmad S; Ahmad SA
Dermatology; 1995; 191(2):129-32. PubMed ID: 8520059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
